IL-10 regulation of macrophage VEGF production is dependent on macrophage polarisation and hypoxia

Immunobiology

Volumn 215, Issue 9-10, 2010, Pages 796-803

  Wu, Wei Kang ^a   Llewellyn, Oliver P C ^a   Bates, David O ^a   Nicholson, Lindsay B ^a   Dick, Andrew D ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Angiogenesis; IL 10; Macrophage; Monocyte; Polarisation; VEGF

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ARGINASE 1; GAMMA INTERFERON; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL HYPOXIA; CELL SPECIFICITY; CELL STIMULATION; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME SYNTHESIS; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION;

ANIMALS; ANOXIA; ARGINASE; CELL DIFFERENTIATION; CELLS, CULTURED; DINOPROSTONE; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; RNA, SMALL INTERFERING; TOLL-LIKE RECEPTOR 4; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77955414334     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2010.05.025     Document Type: Article

References (45)

1. Apte R.S., Richter J., Herndon J., Ferguson T.A. Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med. 2006, 3:e310.
2. Ben Addi A., Lefort A., Hua X., Libert F., Communi D., Ledent C., Macours P., Tilley S.L., Boeynaems J.M., Robaye B. Modulation of murine dendritic cell function by adenine nucleotides and adenosine: involvement of the A(2B) receptor. Eur. J. Immunol. 2008, 38:1610-1620.
3. Breen E.C. VEGF in biological control. J. Cell Biochem. 2007, 102:1358-1367.
4. Broderick C., Duncan L., Taylor N., Dick A.D. IFN-gamma and LPS-mediated IL-10-dependent suppression of retinal microglial activation. Invest. Ophthalmol. Visual Sci. 2000, 41:2613-2622.
5. Carter D.A., Dick A.D. Lipopolysaccharide/interferon-gamma and not transforming growth factor beta inhibits retinal microglial migration from retinal explant. Br. J. Ophthalmol. 2003, 87:481-487.
6. Chen Y., Jiang G., Yang H.R., Gu X., Wang L., Hsieh C.C., Chou H.S., Fung J.J., Qian S., Lu L. Distinct response of liver myeloid dendritic cells to endotoxin is mediated by IL-27. J. Hepatol. 2009, 51:510-519.
7. Cho M., Hunt T.K., Hussain M.Z. Hydrogen peroxide stimulates macrophage vascular endothelial growth factor release. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:H2357-H2363.
8. Chung F. Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-gamma. Mediators Inflammation 2001, 10:51-59.
9. Cohen T., Nahari D., Cerem L.W., Neufeld G., Levi B.Z. Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem. 1996, 271:736-741.
10. Corraliza I.M., Soler G., Eichmann K., Modolell M. Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages. Biochem. Biophys. Res. Commun. 1995, 206:667-673.
11. Dace D.S., Khan A.A., Kelly J., Apte R.S. Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development. PLoS ONE 2008, 3:e3381.
12. Dick A.D., Carter D., Robertson M., Broderick C., Hughes E., Forrester J.V., Liversidge J. Control of myeloid activity during retinal inflammation. J Leukocyte Biol. 2003, 74:161-166.
13. Espinosa-Heidmann D.G., Suner I.J., Hernandez E.P., Monroy D., Csaky K.G., Cousins S.W. Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest. Ophthalmol. Visual Sci. 2003, 44:3586-3592.
14. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 2003, 3:23-35.
15. Hasko G., Pacher P., Deitch E.A., Vizi E.S. Shaping of monocyte and macrophage function by adenosine receptors. Pharmacol. Ther. 2007, 113:264-275.
16. Hasko G., Szabo C., Nemeth Z.H., Kvetan V., Pastores S.M., Vizi E.S. Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J. Immunol. 1996, 157:4634-4640.
17. Kelly J., Ali Khan A., Yin J., Ferguson T.A., Apte R.S. Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice. J. Clin. Invest. 2007, 117:3421-3426.
18. Krishnamurthy P., Rajasingh J., Lambers E., Qin G., Losordo D.W., Kishore R. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ. Res. 2009, 104:e9-18.
19. Ladomery M.R., Harper S.J., Bates D.O. Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm. Cancer Lett. 2007, 249:133-142.
20. Leibovich S.J., Chen J.F., Pinhal-Enfield G., Belem P.C., Elson G., Rosania A., Ramanathan M., Montesinos C., Jacobson M., Schwarzschild M.A., Fink J.S., Cronstein B. Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin. Am. J. Pathol. 2002, 160:2231-2244.
21. Leibovich S.J., Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am. J. Pathol. 1975, 78:71-100.
22. Modolell M., Corraliza I.M., Link F., Soler G., Eichmann K. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur. J. Immunol. 1995, 25:1101-1104.
23. Mosser D.M. The many faces of macrophage activation. J. Leukocyte Biol. 2003, 73:209-212.
24. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
25. Mukutmoni M., Hubbard N.E., Erickson K.L. Prostaglandin E(2) modulation of vascular endothelial growth factor production in murine macrophages. Prostaglandins Leukotrienes Essent. Fatty Acids 2001, 65:123-131.
26. Munder M., Eichmann K., Moran J.M., Centeno F., Soler G., Modolell M. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J. Immunol. 1999, 163:3771-3777.
27. Olah M.E., Caldwell C.C. Adenosine receptors and mammalian toll-like receptors: synergism in macrophages. Mol. Interventions 2003, 3:370-374.
28. Osinsky S., Zavelevich M., Vaupel P. Tumor hypoxia and malignant progression. Exp. Oncol. 2009, 31:80-86.
29. Parmely M.J., Zhou W.W., Edwards C.K., Borcherding D.R., Silverstein R., Morrison D.C. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge. J. Immunol. 1993, 151:389-396.
30. Pinhal-Enfield G., Ramanathan M., Hasko G., Vogel S.N., Salzman A.L., Boons G.J., Leibovich S.J. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. Am. J. Pathol. 2003, 163:711-721.
31. Prabhakar U., Brooks D.P., Lipshlitz D., Esser K.M. Inhibition of LPS-induced TNF alpha production in human monocytes by adenosine (A2) receptor selective agonists. Int. J. Immunopharmacol. 1995, 17:221-224.
32. Qian B., Deng Y., Im J.H., Muschel R.J., Zou Y., Li J., Lang R.A., Pollard J.W. A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS ONE 2009, 4:e6562.
33. Ramanathan M., Pinhal-Enfield G., Hao I., Leibovich S.J. Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter. Mol. Biol. Cell. 2007, 18:14-23.
34. Ray P.S., Jia J., Yao P., Majumder M., Hatzoglou M., Fox P.L. A stress-responsive RNA switch regulates VEGFA expression. Nature 2009, 457:915-919.
35. Rega G., Kaun C., Demyanets S., Pfaffenberger S., Rychli K., Hohensinner P.J., Kastl S.P., Speidl W.S., Weiss T.W., Breuss J.M., Furnkranz A., Uhrin P., Zaujec J., Zilberfarb V., Frey M., Roehle R., Maurer G., Huber K., Wojta J. Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivo. Arteriosclerosis Thromb. Vasc. Biol. 2007, 27:1587-1595.
36. Shen J., Xie B., Dong A., Swaim M., Hackett S.F., Campochiaro P.A. In vivo immunostaining demonstrates macrophages associate with growing and regressing vessels. Invest. Ophthalmol. Visual Sci. 2007, 48:4335-4341.
37. Silvestre J.S., Mallat Z., Duriez M., Tamarat R., Bureau M.F., Scherman D., Duverger N., Branellec D., Tedgui A., Levy B.I. Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb. Circ. Res. 2000, 87:448-452.
38. Stout R.D., Watkins S.K., Suttles J. Functional plasticity of macrophages: in situ reprogramming of tumor-associated macrophages. J. Leukocyte Biol. 2009, 86:1105-1109.
39. Strassmann G., Patil-Koota V., Finkelman F., Fong M., Kambayashi T. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp. Med. 1994, 180:2365-2370.
40. Tammela T., Enholm B., Alitalo K., Paavonen K. The biology of vascular endothelial growth factors. Cardiovasc. Res. 2005, 65:550-563.
41. Tanaka F., Tominaga K., Shiota M., Ochi M., Kuwamura H., Tanigawa T., Watanabe T., Fujiwara Y., Oshitani N., Higuchi K., Iwao H., Arakawa T. Interleukin-10 gene transfer to peritoneal mesothelial cells suppresses peritoneal dissemination of gastric cancer cells due to a persistently high concentration in the peritoneal cavity. Cancer Gene Ther. 2008, 15:51-59.
42. van der Plas M.J., van Dissel J.T., Nibbering P.H. Maggot secretions skew monocyte-macrophage differentiation away from a pro-inflammatory to a pro-angiogenic type. PLoS ONE 2009, 4:e8071.
43. Volk H.D., Reinke P., Krausch D., Zuckermann H., Asadullah K., Muller J.M., Docke W.D., Kox W.J. Monocyte deactivation-rationale for a new therapeutic strategy in sepsis. Intensive Care Med. 1996, 22(Suppl. 4):S474-S481.
44. Xiong M., Elson G., Legarda D., Leibovich S.J. Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am. J. Pathol. 1998, 153:587-598.
45. Yoshida H., Miyazaki Y. Regulation of immune responses by interleukin-27. Immunol. Rev. 2008, 226:234-247.